Henry J. Fuchs - 31 Dec 2021 Form 5 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
President, Worldwide R&D
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
31 Dec 2021
Net transactions value
+$21,281
Form type
5
Filing time
11 Feb 2022, 20:29:57 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $21,281 +341 +0.32% $62.41 106,483 30 Apr 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.